Circulation, Vol 81, 922-928, Copyright © 1990 by American Heart Association
MG Midei, SH DeMent, AM Feldman, GM Hutchins and KL Baughman
The clinical and pathologic features of 18 consecutive patients with
peripartum cardiomyopathy at The Johns Hopkins Hospital were examined in an
attempt to define the incidence of myocarditis and to determine its
response to immunosuppressive agents. In addition to routine studies,
patients were evaluated with echocardiography, nuclear ventriculography,
right heart catheterization, and myocardial biopsy. Fourteen of the 18
patients (78%) showed evidence of myocarditis. Of these, 10 were treated
with immunosuppressive therapy. Nine of the 10 treated patients with
myocarditis had subjective and objective improvement. Follow-up
endomyocardial biopsies in these patients showed resolution or substantial
improvement in myocarditis. Four patients with myocarditis not treated with
immunosuppressives also improved. All patients improving spontaneously
presented with congestive heart failure within 1 month of delivery and
improved dramatically within days of presentation. Four of the 18 patients
showed no evidence of myocarditis. Of these, two improved, and two
deteriorated (both requiring cardiac transplantation). None of these four
patients were treated with immunosuppressive therapy. We conclude that in
patients with peripartum cardiomyopathy, 1) the etiology remains unclear
although myocarditis was present in 78% of those with this condition, 2)
resolution of myocarditis is associated with significant improvement in
left ventricular function, 3) myocarditis may resolve spontaneously without
detectable loss of cardiac function, and 4) immunosuppressive therapy in
patients with myocarditis and persistent left ventricular dysfunction may
improve left ventricular function and prognosis.
ARTICLES
Peripartum myocarditis and cardiomyopathy
Johns Hopkins Medical Institutions, Department of Medicine, Baltimore, Maryland.
This article has been cited by other articles:
 |
|
 |
|
  A mother's heartache: peripartum cardiomyopathy Heart, April 1, 2005; 91(4): 552 - 552. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Ray, G. J. Murphy, and L. E. Shutt Recognition and management of maternal cardiac disease in pregnancy Br. J. Anaesth., September 1, 2004; 93(3): 428 - 439. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Hjalmarson, M. Fu, and R. Mobini Who are the enemies? Inflammation and autoimmune mechanisms Eur. Heart J. Suppl., November 1, 2002; 4(suppl_G): G27 - G32. [Abstract] [PDF]
|
|
|
|
 |
|
 N. J. Mehta, R. N. Mehta, and I. A. Khan Peripartum Cardiomyopathy: Clinical and Therapeutic Aspects Angiology, November 1, 2001; 52(11): 759 - 762. [Abstract] [PDF]
|
|
|
|
 |
|
 P. P. Liu and J. W. Mason Advances in the Understanding of Myocarditis Circulation, August 28, 2001; 104(9): 1076 - 1082. [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Feldman and D. McNamara Myocarditis N. Engl. J. Med., November 9, 2000; 343(19): 1388 - 1398. [Full Text] [PDF]
|
|
|
|
|
|
C. M Oakley GENERAL CARDIOLOGY: Myocarditis, pericarditis and other pericardial diseases Heart, October 1, 2000; 84(4): 449 - 454. [Full Text]
|
|
|
|
 |
|
 M. Bhargava, M. Singh, P. V. Suresh, R. Juneja, H. K. Bali, J. Varma, M. Bhargava, M. Singh, P. V. Suresh, R. Juneja, et al. Unusual Left Ventricular Function and Survival in Peripartum Cardiomyopathy Asian Cardiovasc Thorac Ann, June 1, 2000; 8(2): 155 - 157. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Sliwa, D. Skudicky, A. Bergemann, G. Candy, A. Puren, and P. Sareli Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1 J. Am. Coll. Cardiol., March 1, 2000; 35(3): 701 - 705. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. D. Pearson, J.-C. Veille, S. Rahimtoola, J. Hsia, C. M. Oakley, J. D. Hosenpud, A. Ansari, and K. L. Baughman Peripartum Cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) Workshop Recommendations and Review JAMA, March 1, 2000; 283(9): 1183 - 1188. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Lindner, M. P. Coggins, S. Kaul, A. L. Klibanov, G. H. Brandenburger, and K. Ley Microbubble Persistence in the Microcirculation During Ischemia/Reperfusion and Inflammation Is Caused by Integrin- and Complement-Mediated Adherence to Activated Leukocytes Circulation, February 15, 2000; 101(6): 668 - 675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. U. Hibbard, M. Lindheimer, and R. M. Lang A MODIFIED DEFINITION FOR PERIPARTUM CARDIOMYOPATHY AND PROGNOSIS BASED ON ECHOCARDIOGRAPHY Obstet. Gynecol., August 1, 1999; 94(2): 311 - 316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Bozkurt, F. S. Villaneuva, R. Holubkov, T. Tokarczyk, R. J. Alvarez Jr., G. A. MacGowan, S. Murali, W. D. Rosenblum, A. M. Feldman, and D. M. McNamara Intravenous immune globulin in the therapy of peripartum cardiomyopathy J. Am. Coll. Cardiol., July 1, 1999; 34(1): 177 - 180. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Borczuk, K. H. van Hoeven, and S. M. Factor Review and hypothesis: the eosinophil and peripartum heart disease (myocarditis and coronary artery dissection)--coincidence or pathogenetic significance? Cardiovasc Res, March 1, 1997; 33(3): 527 - 532. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Airoldi, O. Eid, C. Tosetto, and P. Meroni Post-partum dilated cardiomyopathy in anti-phospholipid positive woman Lupus, June 1, 1996; 5(3): 247 - 250. [Abstract] [PDF]
|
|
|
|
|
|
L. G. Lange and G. F. Schreiner Immune Mechanisms of Cardiac Disease N. Engl. J. Med., April 21, 1994; 330(16): 1129 - 1135. [Full Text]
|
|
|
|
|
|
N. K. Wenger, L. Speroff, and B. Packard Cardiovascular Health and Disease in Women N. Engl. J. Med., July 22, 1993; 329(4): 247 - 256. [Full Text]
|
|